JP2024533312A5 - - Google Patents

Info

Publication number
JP2024533312A5
JP2024533312A5 JP2024515068A JP2024515068A JP2024533312A5 JP 2024533312 A5 JP2024533312 A5 JP 2024533312A5 JP 2024515068 A JP2024515068 A JP 2024515068A JP 2024515068 A JP2024515068 A JP 2024515068A JP 2024533312 A5 JP2024533312 A5 JP 2024533312A5
Authority
JP
Japan
Prior art keywords
sequence
grna
template rna
mutation
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024515068A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024533312A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/076073 external-priority patent/WO2023039447A2/en
Publication of JP2024533312A publication Critical patent/JP2024533312A/ja
Publication of JP2024533312A5 publication Critical patent/JP2024533312A5/ja
Pending legal-status Critical Current

Links

JP2024515068A 2021-09-08 2022-09-07 Serpina調節組成物及び方法 Pending JP2024533312A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163241970P 2021-09-08 2021-09-08
US63/241,970 2021-09-08
US202163253087P 2021-10-06 2021-10-06
US63/253,087 2021-10-06
US202263303905P 2022-01-27 2022-01-27
US63/303,905 2022-01-27
PCT/US2022/076073 WO2023039447A2 (en) 2021-09-08 2022-09-07 Serpina-modulating compositions and methods

Publications (2)

Publication Number Publication Date
JP2024533312A JP2024533312A (ja) 2024-09-12
JP2024533312A5 true JP2024533312A5 (cg-RX-API-DMAC7.html) 2025-09-17

Family

ID=85506923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024515068A Pending JP2024533312A (ja) 2021-09-08 2022-09-07 Serpina調節組成物及び方法

Country Status (7)

Country Link
US (1) US20240084334A1 (cg-RX-API-DMAC7.html)
EP (1) EP4399309A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024533312A (cg-RX-API-DMAC7.html)
AU (1) AU2022344251A1 (cg-RX-API-DMAC7.html)
CA (1) CA3231594A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024002988A (cg-RX-API-DMAC7.html)
WO (1) WO2023039447A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
AU2019327449B2 (en) 2018-08-28 2026-04-09 Flagship Pioneering Innovations Vi, Llc Methods and compositions for modulating a genome
IL296095A (en) 2020-03-04 2022-11-01 Flagship Pioneering Innovations Vi Llc Improved methods and compositions for genome modulation
BR112022017715A2 (pt) 2020-03-04 2022-11-16 Flagship Pioneering Innovations Vi Llc Métodos e composições para modular um genoma
CA3177481A1 (en) 2020-05-08 2021-11-11 David R. Liu Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
KR20260037664A (ko) 2021-09-08 2026-03-18 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 게놈을 조절하기 위한 방법 및 조성물
CA3231712A1 (en) 2021-09-08 2023-03-16 Flagship Pioneering Innovations Vi, Llc Pah-modulating compositions and methods
IL312965A (en) * 2021-11-24 2024-07-01 Flagship Pioneering Innovations Vi Llc Immunogenic compositions and their uses
EP4444362A4 (en) 2021-12-10 2026-04-01 Flagship Pioneering Innovations Vi Llc CFTR COMPOSITIONS AND MODULATION METHODS
WO2025155773A1 (en) * 2024-01-19 2025-07-24 Gene Company (Pty)Ltd. Telomerase upregulating polynucleotide and method of use and treatment thereof
WO2025181704A2 (en) * 2024-02-27 2025-09-04 Crispr Therapeutics Ag Rt editing compositions and methods
WO2025194124A1 (en) * 2024-03-14 2025-09-18 Tessera Therapeutics, Inc. Modified st1cas9 guide nucleic acids
WO2025194133A1 (en) * 2024-03-15 2025-09-18 Beam Therapeutics Inc. Prime editing of single base mutations in alpha-1 antitrypsin deficiency

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2916499A1 (en) * 2013-07-03 2015-01-08 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded rna
WO2017093804A2 (en) * 2015-12-01 2017-06-08 Crispr Therapeutics Ag Materials and methods for treatment of alpha-1 antitrypsin deficiency
EP3433364A1 (en) * 2016-03-25 2019-01-30 Editas Medicine, Inc. Systems and methods for treating alpha 1-antitrypsin (a1at) deficiency
IL264439B2 (en) * 2016-08-17 2024-08-01 Factor Bioscience Inc non-viral, cell-free composition comprising a synthetic messenger RNA (MRNA) encoding a gene-editing protein for use in treating cancer, and a synthetic RNA encoding a gene-editing protein for use in treatment
JP7256739B2 (ja) * 2016-09-07 2023-04-12 サンガモ セラピューティクス, インコーポレイテッド 肝臓遺伝子のモジュレーション
WO2020191241A1 (en) * 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
TWI887234B (zh) * 2019-04-14 2025-06-21 美國公爵大學 治療杜興氏(duchenne)肌肉失養症之大型突變熱點之aav載體介導之刪除
US12435330B2 (en) * 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA

Similar Documents

Publication Publication Date Title
JP2024533313A5 (cg-RX-API-DMAC7.html)
JP2024533315A5 (cg-RX-API-DMAC7.html)
JP2024533311A5 (cg-RX-API-DMAC7.html)
US20180073018A1 (en) Compositions and methods for specific reactivation of hiv latent reservoir
JP2024533311A (ja) ゲノムを調節するための方法及び組成物
US20240424138A1 (en) Genome editing compositions and method for treatment of retinitis pigmentosa
JP2024533312A (ja) Serpina調節組成物及び方法
US20250297246A1 (en) Modified prime editing guide rnas
US20230374476A1 (en) Prime editor system for in vivo genome editing
US20250073352A1 (en) Genome editing compositions and methods for treatment of fragile x syndrome
JP2022513459A5 (cg-RX-API-DMAC7.html)
WO2024131940A1 (zh) 融合物及其用途
JP2020530463A (ja) ウイルスの細胞内送達のためのペプチドおよびナノ粒子
US20250011766A1 (en) Genome Editing Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosis
JP7736329B2 (ja) Dux4遺伝子を標的とした顔面肩甲上腕型筋ジストロフィーの治療方法
WO2024238321A1 (en) Compositions and methods for targeted epigenetic modification
US20240175053A1 (en) Factor VIII Molecules and Their Use
KR102876548B1 (ko) Francisella novicida Cas9 모듈 기반의 역전사 효소를 사용한 유전체 치환 및 삽입 기술
EP4399308A1 (en) Recruitment in trans of gene editing system components
WO2023028180A2 (en) Genome editing compositions and methods for treatment of retinopathy
US20240376466A1 (en) Genome editing compositions and methods for treatment of fanconi anemia
WO2022003608A1 (en) Mirna-485 inhibitor for huntington's disease
IL323066A (en) PAH Modulating Systems and Methods
JP2026509461A (ja) Serpina調節性組成物及び方法
JP2024522216A (ja) インフラマソーム関連疾患または障害を治療するためのmirna-485阻害剤の使用